European Commission approves Lilly's Emgality for migraine

20th November 2018 Uncategorised 0

Eli Lilly has confirmed that Emgality has been approved by the European Commission for preventive treatment of migraine in adults who have at least four migraine days per month.

More: European Commission approves Lilly's Emgality for migraine
Source: News